
Opinion|Videos|November 19, 2025
Improving Care for mCRC: Overcoming Barriers and Building Confidence in Community Practice
Panelists discuss how addressing barriers and sharing real-world data can increase community confidence in prescribing third-line metastatic colorectal therapies.
Advertisement
Episodes in this series

Panelists highlight barriers in community practice that limit third-line therapy uptake, including lack of familiarity with new agents and limited access to data.
They discuss strategies such as sharing real-world safety and patient-reported outcomes data, educational initiatives, and peer-to-peer engagement to build clinician confidence.
Improving data dissemination and support structures can help ensure more patients receive evidence-based therapies outside academic centers.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next
3
Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care
4
Beyond GLP-1: The Biological Case for Dual Incretin Therapy in MASH
5





